Page 2 : Venture Capital Insights, Trends & Strategies for Founders and Investors

Spotlight

Series A funding requirements in 2026: the real bar founders need to clear

The Process of Venture Funding

•

12/05/2026

Series A funding requirements in 2026: the real bar founders need to clear

Detailed guide to modern Series A funding requirements: ARR and growth benchmarks, burn multiple expectations, team and governance signals, market-fit evidence, and how these metrics translate into real term-sheet dynamics for founders.

The IC memo anatomy: what partners actually read before the vote

The Process of Venture Funding

•

03/05/2026

The IC memo anatomy: what partners actually read before the vote

How CEOs should read and shape a VC investment committee memo, from risk narrative and valuation to bear cases, governance, and long term capital strategy.

by Jean-Christophe Durand

Zero Shot and the new emerging manager template: what OpenAI alumni funds teach allocators

Types of Venture Funds

•

27/04/2026

Zero Shot and the new emerging manager template: what OpenAI alumni funds teach allocators

How emerging manager venture funds like Zero Shot are reshaping operator-led VC, LP diligence, and CEO-investor dynamics, with concrete mechanics and strategic implications.

by Wan-Ling Chen

The 2026 term sheet pendulum: why participating preferred is back on the table

The Process of Venture Funding

•

28/04/2026

The 2026 term sheet pendulum: why participating preferred is back on the table

Participating preferred term sheets are reshaping venture capital outcomes. Learn how liquidation preferences, participation rights, and bridge round terms shift value between preferred and common shareholders, and how founders and boards can negotiate smarter.

by Wan-Ling Chen

Term sheet negotiation tips that actually move the needle for founders

The Process of Venture Funding

•

07/05/2026

Term sheet negotiation tips that actually move the needle for founders

Practical term sheet negotiation guide for CEOs: how liquidation preferences, participation, pay-to-play, board control, and protective provisions really shape founder dilution and exit outcomes, with data-backed benchmarks and example clauses.

by Wan-Ling Chen

Crusoe at $10B: pricing AI infrastructure when the SaaS comparables stop working

Evaluating Startups for Investment

•

23/04/2026

Crusoe at $10B: pricing AI infrastructure when the SaaS comparables stop working

Crusoe’s $1.38B Series E shows AI infrastructure venture capital is a distinct asset class. How CEOs should rethink valuation, capital structure, and sector-focused funds.

by Ava Henderson

Startup valuation methods in 2026: when Berkus, DCF, and scorecard actually apply

Evaluating Startups for Investment

•

08/05/2026

Startup valuation methods in 2026: when Berkus, DCF, and scorecard actually apply

A CEO level guide to startup valuation methods, from Berkus and Scorecard to DCF, comparables, and AI era distortions, with practical tactics for venture rounds.

$Founders, read the megadeal math: what concentrated AI funding actually does to your round$

Current Trends in Venture Capital

•

24/04/2026

Founders, read the megadeal math: what concentrated AI funding actually does to your round

AI funding concentration is reshaping venture capital. Learn how LP reallocation, mega-rounds, and changing acquirer behavior affect follow-on capital, board expectations, and exit math—and what founders can do to keep negotiating power.

by Leonardo Agostini

Q1 2026 funding roundup: the deals, funds, and valuations that reset the benchmarks

Current Trends in Venture Capital

•

21/04/2026

Q1 2026 funding roundup: the deals, funds, and valuations that reset the benchmarks

Detailed Q1 2026 VC funding roundup for CEOs, covering valuations, round sizes, AI and infrastructure trends, sector shifts, exits, and M&A signals across global venture capital markets.

by Tanisha Patel

Four rounds, 65% of global VC: what the Q1 2026 mega-round concentration means for your thesis

Current Trends in Venture Capital

•

20/04/2026

Four rounds, 65% of global VC: what the Q1 2026 mega-round concentration means for your thesis

Analysis of Q1 2026 venture capital mega rounds: how 188B dollars in AI-focused financings reshaped global VC allocation, LP behavior, and CEO fundraising strategy outside the frontier lab oligopoly.

by Elias Raphael

How venture capital funds actually work: the mechanics behind the pitch deck theatre

Understanding Venture Capital

•

04/05/2026

How venture capital funds actually work: the mechanics behind the pitch deck theatre

A deep, practical guide for CEOs and aspiring VCs on how venture capital funds work, from LP-GP structures and fees to J-curves, portfolio construction, and returns.

by Tanisha Patel

The venture capital due diligence checklist founders should run on themselves before the pitch

Evaluating Startups for Investment

•

22/04/2026

The venture capital due diligence checklist founders should run on themselves before the pitch

Learn how CEOs can use a venture capital due diligence checklist to prepare for institutional investors, structure data rooms, avoid red flags, and position their startups for Series A, growth equity, and private equity funding.

by Isabella Fiorentino

Strategic shifts in the investment landscape for aerospace companies in the United Kingdom

Understanding Venture Capital

•

11/04/2026

Strategic shifts in the investment landscape for aerospace companies in the United Kingdom

Strategic analysis of the evolving investment landscape for aerospace companies in the United Kingdom, focusing on technology, capital, defence, and regional ecosystems.

by Ava Henderson

How private equity interest in consumer brands is reshaping strategic leadership

Understanding Venture Capital

•

10/04/2026

How private equity interest in consumer brands is reshaping strategic leadership

How private equity interest in consumer brands is reshaping CEO strategy, governance, and value creation across consumer goods, food, beverage, and retail sectors.

by Isabella Fiorentino

How to maximize small company value in a demanding market

Understanding Venture Capital

•

10/04/2026

How to maximize small company value in a demanding market

Strategic guide for CEOs on maximizing small company value through robust valuation methods, cash flow discipline, and asset management in competitive markets.

by Otis Blackwood

Strategic linear asset management for CEOs steering critical infrastructure

The Process of Venture Funding

•

10/04/2026

Strategic linear asset management for CEOs steering critical infrastructure

Strategic guide for CEOs on linear asset management, linking SAP, EAM, data, and governance to performance, risk, and infrastructure resilience.

by Elias Raphael

What brightflag acquired by Wolters Kluwer means for corporate legal strategy

The Role of Angel Investors and Incubators

•

10/04/2026

What brightflag acquired by Wolters Kluwer means for corporate legal strategy

Analysis for CEOs on what brightflag acquired by Wolters Kluwer means for corporate legal strategy, capital allocation, risk governance, and legal technology choices.

by Elias Raphael

How to turn investor relations vacancies into a strategic advantage for your company

Understanding Venture Capital

•

19/03/2026

How to turn investor relations vacancies into a strategic advantage for your company

How CEOs can turn investor relations vacancies into a strategic advantage, aligning finance, reporting, and capital markets while strengthening long term leadership.

by Harold McBride

Why PayPal’s 300 million technology restructuring is a pivotal test for digital payments leadership

Emerging Technologies and Markets

•

18/03/2026

Why PayPal’s 300 million technology restructuring is a pivotal test for digital payments leadership

An in depth analysis of PayPal’s 300 million technology restructuring and what CEOs can learn about digital payments strategy, risk, and large scale transformation.

by Leonardo Agostini

How synthetic biology venture capital firms are reshaping biotech company strategy

Understanding Venture Capital

•

17/03/2026

How synthetic biology venture capital firms are reshaping biotech company strategy

How CEOs can work with synthetic biology venture capital firms to shape biotech strategy, manage funding stages, and build high impact innovation portfolios.

by Elias Raphael